INSUBCONTINENT EXCLUSIVE:
Oviva, the health tech startup that provides a digital solution for Type 2 diabetes treatment in Europe, has raised $21 million in Series B
funding.Leading the round is MTIP, with participation by new investor Earlybird, and existing investors AlbionVC, F-Prime Capital, Eight
Roads Ventures and Partech.Oviva says the new capital will be used to further develop its technology, and continue expanding in Europe to
serve more patients not able to currently aaccess treatment
It brings the total raised by Oviva to date to $34 million.Claiming to have treated 90,000 patients in the last three years across the U.K.,
diabetes and obesity-related conditions
Patients receive tailored nutrition advice and personalised coaching via their phone, at lower costs and better outcomes compared to
You are then treated typically for four to nine months, depending on your condition and local reimbursement
After that time you can continue, paying yourself, or get another referral (typically annually, as our behaviour-change treatment is
on-boarded, they start logging anything that is important related to their lifestyle and disease
This includes photos of meals, activity, weight and symptoms
They can also connect a step counter, weight scale or blood glucose meter to the app to complete most of the data collection
On the one hand that is motivation and emotional support, on the other hand with specific pointers targeted to your needs, e.g
have video-call appointments with their dietitian, and review a curriculum of videos and other content supporting the management of their
